Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into a variety of cell types, including but not limited to osteoblasts, chondrocytes, myocytes, and adipocytes. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are advantageous over other stem cells types for a variety of reasons, including that they are immuno-privileged, making them an advantageous cell type for allogenic transplantation. [Read more…]
Press Releases: Press releases are provided by the issuer and may be published by BioInformant as paid content. The issuer is solely responsible for the content and claims contained within these announcements. BioInformant does not independently verify or endorse the claims made by the issuer. For questions about an individual Press Release or to submit one, write us at [email protected].
iOrganBio Emerges from Stealth with $2M and Launches CellForge™, the First AI-Powered Cell Manufacturing Platform
Founded by deep scientific experts across biomedical engineering, stem cell biology and organoid systems
Funding round led by First Star Ventures
October 29, 2025, CHAPEL HILL, NC — iOrganBio announced its launch from stealth with $2 million in funding to transform how human cells are made. The round was led by First Star Ventures along with institutional investors IndieBio, Cape Fear BioCapital, 2ndF, Terasaki Institute, and Alix Ventures. [Read more…]
BBG Advanced Therapies collects first cell donation on one-of-a-kind bus
New vehicle to help enable lifesaving new advanced therapies
The world’s only mobile leukapheresis center recorded its first donation on Monday, Oct. 20, marking the beginning of a new era for global healthcare.
The BBG Advanced Therapies mobile leukapheresis center, the first of its kind in the world, can help improve access to lifesaving treatments across an area of almost 70,000 square miles currently underserved by next-generation advanced therapies. [Read more…]
Qkine launches cell therapy grade recombinant proteins to support next-generation therapies
1st October 2025, Cambridge, UK – Qkine, Ltd., a specialist bioactive protein manufacturer with its core technology developed at the University of Cambridge, today announced the launch of its Cell Therapy Grade proteins, engineered to support the stringent requirements of cell therapy research, process development, and GMP manufacturing. [Read more…]
TEDCO Announces Panel to Discuss the Road to Clinical Trials at 2025 Entrepreneur Expo
COLUMBIA, Md., October 9, 2025 — TEDCO, Maryland’s economic engine for technology companies, announces the panel “The Road to Clinical Trials” to take place at the upcoming 2025 Entrepreneur Expo at The Hotel at the University of Maryland on October 21, 2025.
“The transition from discovery to clinical application represents one of the most complex and pivotal phases of medical research” said Ben Antebi, associate director, Maryland Stem Cell Research Fund (MSCRF). “Navigating this critical pathway properly has a direct impact on shaping the fate of a technology.” [Read more…]
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 146
- Next Page »